Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;13(3):1535-1538.
doi: 10.3892/ol.2017.5639. Epub 2017 Jan 25.

Smad3 mutant mice develop colon cancer with overexpression of COX-2

Affiliations

Smad3 mutant mice develop colon cancer with overexpression of COX-2

Yu-Ping Zhu et al. Oncol Lett. 2017 Mar.

Abstract

Colon cancer is the second most common cause of cancer-associated mortality in human populations. The aim of the present study was to identify the role of cyclooxygenase-2 (COX-2) in Smad3 mutant mice, which are known to develop colon cancer. Homozygous Smad3 (-/-) mutant mice were generated from inbred and hybrid Smad3 mouse strains by intercrossing the appropriate heterozygotes. Immunohistochemistry with COX-2 antibody was performed throughout this experiment and the data was validated and cross-checked with reverse transcription-polymerase chain reaction (RT-PCR). Homozygous mutant Smad3 mice were generated and the overexpression pattern of COX-2 was identified by immunohistochemistry and validated with RT-PCR. The results of the present study demonstrated a link between the Smad3 mutant mice, colon cancer and COX-2. In addition, the overexpression pattern of COX-2 in Smad3 mutant mice that develop colon cancer was identified.

Keywords: Smad3; colon cancer; cyclooxygenase-2; p53.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The expression pattern of Smad3 in normal and homozygous mutant Smad3 (−/−) mice was identified by whole-mount in situ hybridization of embryos at day 11.5 (A) Whole mount in situ hybridization of control E11.5 embryo taken from a healthy mouse. (B) Whole mount in situ hybridization of homozygous mutant Smad3 mouse E11.5 embryo. (C) Whole mount in situ hybridization of control colon taken from a healthy mouse. (D) Whole mount in situ hybridization of homozygous mutant Smad3 mouse colon. Representative images from three replicate experiments are presented here.
Figure 2.
Figure 2.
Immunohistochemistry with anti-COX-2 antibodies. (A) Few COX-2-positive cells were noted in the control tissue section. (B) COX-2 overexpression was observed in homozygous mutant Smad3 mouse tissue. Positive cells are indicated by brown staining. Representative images from three replicate experiments are presented here. Magnification, ×20. COX-2, cyclooxygenase-2.
Figure 3.
Figure 3.
Reverse transcription-polymerase chain reaction analysis. Overexpression profile of COX-2 with Smad3, P53 (along with the control β-actin) in the control and homozygous mutant Smad3 mice. Representative blots from three replicate experiments are presented here. COX-2, cyclooxygenase-2.

References

    1. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545. doi: 10.1093/oxfordjournals.epirev.a036132. - DOI - PubMed
    1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117. doi: 10.3322/caac.21220. - DOI - PubMed
    1. Tomlinson I, Ilyas M, Novelli M. Molecular genetics of colon cancer. Cancer Metastasis Rev. 1997;16:67–79. doi: 10.1023/A:1005744323215. - DOI - PubMed
    1. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 1998;94:703–714. doi: 10.1016/S0092-8674(00)81730-4. - DOI - PubMed
    1. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol. 1996;179:297–302. doi: 10.1006/dbio.1996.0259. - DOI - PubMed